EVFM

Evofem Biosciences (EVFM)

About Evofem Biosciences (EVFM)

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes innovative products to unmet needs in women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.

Details

Daily high
$0.01
Daily low
$0.01
Price at open
$0.01
52 Week High
$0.23
52 Week Low
$0.01
Market cap
963,200
Dividend yield
0.00%
Volume
899,222
Avg. volume
874,445
P/E ratio
-.01

Evofem Biosciences News

Details

Daily high
$0.01
Daily low
$0.01
Price at open
$0.01
52 Week High
$0.23
52 Week Low
$0.01
Market cap
963,200
Dividend yield
0.00%
Volume
899,222
Avg. volume
874,445
P/E ratio
-.01